Motilal Oswal's report on Shriram Transport Finance
Despite migration to 120dpd (15% of GNPA), management kept its focus on balance sheet strength. PCR declined to just 70% from 75% a quarter ago. Hence, provisioning was higher than estimate and led to in-line PAT.
Outlook
We cut our FY18-19 estimates by 6%/2% to factor in slower AUM growth and higher PCR. The stock trades at 1.9x/1.6x FY18/19E BV. BUY with a TP of INR 1,269 (2x FY19E BVPS).
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
